Remeglurant (; developmental code name MRZ-8456) is a
drug which acts as a
selective antagonist of the
mGlu5 receptor.
It is under development by Merz Pharmaceuticals for the treatment of
drug-induced dyskinesia but no development has been reported since at least 2016.
See also
*
Basimglurant
*
Dipraglurant
Dipraglurant ( INN) (code name ADX-48621) is a negative allosteric modulator of the mGlu5 receptor which is under development by Addex Therapeutics for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID). As of 2014, it i ...
*
Fenobam
*
Mavoglurant
*
Raseglurant
Raseglurant ( INN) (code name ADX-10059) is a negative allosteric modulator of the mGlu5 receptor and derivative of MPEP which was under development by Addex Therapeutics for the treatment of migraine, gastroesophageal reflux disease, and den ...
References
Isoquinolines
MGlu5 receptor antagonists
Organobromides
Pyrimidines
{{Nervous-system-drug-stub